Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-28

Clinical Trial Update: Carbamazepine Treatment for Cocaine Dependence - 5 [Phase 2]

View source ↗

Summary

A Phase 2 trial at the University of Pennsylvania evaluated carbamazepine for cocaine use disorder and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

Sponsor: University of Pennsylvania | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED